Journal article
Urinary 11‐Dehydro‐Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
Abstract
BACKGROUND: Urinary 11-dehydro-thromboxane (TX)B2 has been described as a potential predictive biomarker of major adverse cardiovascular events (MACEs) in high cardiac risk patients. This part of LTIMI (Leukotrienes and Thromboxane In Myocardial Infarction) study aimed to evaluate the relationship between 11-dehydro-TXB2 and MACEs in patients with acute myocardial infarction (AMI).
METHODS AND RESULTS: LTIMI was an observational, prospective …
Authors
Szczeklik W; Stodółkiewicz E; Rzeszutko M; Tomala M; Chrustowicz A; Żmudka K; Sanak M
Journal
Journal of the American Heart Association, Vol. 5, No. 8,
Publisher
Wolters Kluwer
Publication Date
August 8, 2016
DOI
10.1161/jaha.116.003702
ISSN
2047-9980